1967
Guy Barouh establishes Sebia
Company Overview
Our new language of life: a commitment to improve people health worldwide.
Our mission
Our mission is to provide healthcare professionals with powerful tools that translate complex biological signals into clear, actionable insights.
We call it our new language of life.
This language helps reveal the biological signatures behind complex and chronic diseases, enabling earlier detection, more accurate diagnosis and better patient management. From oncology and hematology to autoimmune, metabolic and infectious diseases, many conditions are driven by subtle changes in proteins, antibodies and other biomarkers that require specialized analytical approaches to be fully understood.
At Sebia, we combine scientific expertise, innovative technologies and deep clinical knowledge to make these biological patterns visible and clinically meaningful.
Who We Are
Sebia is a global specialized In Vitro Diagnostic company providing systems and reagents for the screening, diagnosis and monitoring of diseases in Oncology, Diabetes, Hemoglobinopathies, Autoimmune and Infectious Diseases, as well as other rare disorders.
Founded in 1967 and headquartered near Paris, France, Sebia has built a unique expertise in specialty diagnostics and protein analysis. In the early 2000s, the company pioneered the introduction of Capillary Electrophoresis in clinical diagnostics, establishing a new standard for automation, performance and diagnostic confidence.
Today, while continuing to advance its leadership in Capillary Electrophoresis, Sebia is expanding its footprint in autoimmunity, bringing innovative solutions that complement its historical strengths and support clinicians across a broader spectrum of patient needs.
Driven by scientific excellence, technological innovation and strong manufacturing capabilities, Sebia continues to develop new assays and automated platforms that help laboratories deliver answers that matter for patients worldwide.
1,500+
employees worldwide
23
affiliates and representative offices
6
manufacturing sites
120+
countries served
20k+
instruments installed worldwide
Our mission is to provide powerful tools that translate what is happening in a patient's body into a readable and interpretable language.
Our history
Your Specialty Diagnostic Company, built on 60+ years of trusted expertise, empowering laboratories and healthcare professionals worldwide with innovative solutions to detect, monitor, and understand diseases—from oncology, diabetes and hemoglobinopathies to autoimmune and rare disorders.
1986
Launch of the HYDRAGEL range of products
1994
Introduction of the First HYDRASYS system
1997
Opening of the U.S. subsidiary
2001
Sebia introduces Capillary Electrophoresis (CE) technology
2004
Opening of the Lisses Headquarters in France
2005
First CAPILLARYS 2 system sold
2007
Introduction of CE test for Hb
2011
Introduction of a CE test for HbA1c
2015
First CAPILLARYS 3 TERA system sold
2017
Introduction of the CAPILLARYS 3 TERA MC system
2017
Jean-Marc CHERMETTE is named CEO
2019
Extended CAPILLARYS 3 Family of Instruments (OCTA & TLA System)
2021
First CAPILLARYS 3 DBS system sold
2021
Acquisition of Orgentec & launch of Alegria 2
2022
Acquisition of Zeus Scientific
2024
Launch of the IFA Automation Family of Instruments
2026
Launch of the Alegria Flash
Learn more
Our R&D teams have 60 years of unique experience, perspective and knowledge.
Within the Sebia Group everything is possible. If you want to live a great professional adventure, Join us!
Over the years, Sebia has continuously strengthened its international footprint to better serve its customers.
Employee testimonials
Find out what the role of a Chemistry Production Manager at Sebia is.
Find out what the role of a R&D Manager at Sebia is.
Find out what the role of a Knowledge Center Advisor at Sebia is.